CMKLR1 and Hyperinsulinemia: this context, recent studies demonstrate that the ability of the EPA-derived SPM RvE1 to reverse hyperinsulinemia and hyperglycemia in obese outbred mice was linked with SNPs identified in its cognate receptor ERV1/ChemR23 [49].